Global Cancer Monoclonal Antibodies Markets, 2016-2021, 2021-2026F, 2031F: Bevacizumab (Avastin); Rituximab (Rituxan); Trastuzumab (Herceptin); Cetuximab (Erbitux); Panitumumab (Vectibix)
20 juin 2022 04h23 HE
|
Research and Markets
Dublin, June 20, 2022 (GLOBE NEWSWIRE) -- The "Cancer Monoclonal Antibodies Global Market Report 2022: By Monoclonal, By Application, By End-User" report has been added to ResearchAndMarkets.com's...
Global Immuno-Oncology Diagnostics Market Research Report 2022-2026: Diagnostics Plays New Key Role in Therapeutic Development and Clinical Trials
08 juin 2022 03h53 HE
|
Research and Markets
Dublin, June 08, 2022 (GLOBE NEWSWIRE) -- The "Market Forecasts for Immuno-Oncology Diagnostics, Including Executive/Consultant Guides and Customized Forecasting/Analysis 2022 - 2026" report has...
Immuno-Oncology Drug Development Analytical Tool 2022: 1260 Companies/Partners Who are Developing 3,896 I-O Drugs Where of 2,948 are in Active Development in Cancer Across 629 Different Targets
26 mai 2022 06h28 HE
|
Research and Markets
Dublin, May 26, 2022 (GLOBE NEWSWIRE) -- The "Immuno-Oncology Drug Development: Analytical Tool" report has been added to ResearchAndMarkets.com's offering. Immuno-Oncology Drug Development:...
Sensei Biotherapeutics to Participate in Jefferies Healthcare Conference
25 mai 2022 07h30 HE
|
Sensei Biotherapeutics
BOSTON, May 25, 2022 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), an immunotherapy company focused on the discovery and development of next generation therapeutics for cancer,...
Sensei Biotherapeutics Reports First Quarter 2022 Financial Results and Recent Business Highlights
10 mai 2022 07h30 HE
|
Sensei Biotherapeutics
- SNS-101 preclinical data provide encouraging validation of pH-sensitive approach to inhibiting VISTA with high selectivity to treat solid tumors - - Cash runway extended into the first quarter of...
Global Immuno-Oncology Diagnostics Market Research Report 2022: Explosion in Immuno-Oncology Therapies Creates an Exploding Diagnostic Market - Forecast to 2027
29 mars 2022 04h13 HE
|
Research and Markets
Dublin, March 29, 2022 (GLOBE NEWSWIRE) -- The "Market Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates" report has been added to ResearchAndMarkets.com's offering....
$3.27 Billion Worldwide Oncology Biosimilars Industry to 2031 - Identify Growth Segments for Investment
22 mars 2022 05h33 HE
|
Research and Markets
Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "Oncology Biosimilars Global Market Report 2022: By Drug, By Cancer, By Distribution" report has been added to ResearchAndMarkets.com's offering. This...
Autolus Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on March 10
21 févr. 2022 07h00 HE
|
Autolus Therapeutics plc
LONDON, Feb. 21, 2022 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced...
Global $49.77 Cancer Monoclonal Antibodies Markets Analysis & Forecasts, 2015-2020, 2020-2025F, 2030F
10 janv. 2022 05h18 HE
|
Research and Markets
Dublin, Jan. 10, 2022 (GLOBE NEWSWIRE) -- The "Cancer Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering....
Worldwide Immuno Oncology Assays Industry to 2026 - Clinical Trials to Cure Different Cancers in Immunotherapy Presents Opportunities
05 janv. 2022 06h38 HE
|
Research and Markets
Dublin, Jan. 05, 2022 (GLOBE NEWSWIRE) -- The "Immuno Oncology Assays Market Research Report by Indication, Product, Technology, Application, and Region - Global Forecast to 2026 - Cumulative Impact...